Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD 0.0110
0.00 (0.00%)
Apr 16, 2026, 3:52 PM AEST
Acrux Market Cap
Acrux has a market cap or net worth of 4.52 million as of April 17, 2026. Its market cap has decreased by -64.91% in one year.
Market Cap
4.52M
Enterprise Value
5.77M
Revenue
2.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 90.77M to 4.52M, a decrease of -95.02%. That is a compound annual growth rate of -12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.52M | -26.67% |
| Dec 31, 2025 | 6.16M | -53.60% |
| Dec 31, 2024 | 13.27M | 4.16% |
| Dec 29, 2023 | 12.74M | -36.43% |
| Dec 30, 2022 | 20.05M | -29.33% |
| Dec 31, 2021 | 28.37M | -18.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Gene Technology | 11.59M |
| Immuron | 11.43M |
| Tissue Repair | 10.28M |
| AdAlta | 10.20M |
| Chimeric Therapeutics | 8.84M |
| Vectus Biosystems | 8.02M |
| Invex Therapeutics | 6.99M |
| Biotron | 6.75M |